Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) EPS (Diluted) (2020 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 1.44
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 4.25
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -0.02
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 2.51
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -0.14
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -0.84
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -0.05
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -
10 VivoSim Labs 1.47 Mn 1.47 Mn - -0.52
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.84
Mar 31, 2026 -1.49
Dec 31, 2025 -1.46
Sep 30, 2025 -1.45
Jun 30, 2025 -1.10
Mar 31, 2025 -1.68
Dec 31, 2024 -2.07
Sep 30, 2024 -1.08
Jun 30, 2024 -4.23
Mar 31, 2024 -3.31
Dec 31, 2023 -4.35
Sep 30, 2023 -6.21
Jun 30, 2023 -3.59
Mar 31, 2023 -4.28
Dec 31, 2022 -4.12
Sep 30, 2022 -16.44
Jun 30, 2022 -16.55
Mar 31, 2022 -14.69
Dec 31, 2021 -47.19
Sep 30, 2021 -3.09